DebtManagement
-
When Cramer Says Buy, I Check the Exit
When Jim Cramer says “buy,” the real question isn’t what he likes. It’s whether you’re late. This week he’s pounding the table on Marvell (MRVL) and Bausch Health (BHC). One is an AI infrastructure darling with hyperscaler tailwinds. The other is a battered pharma turnaround story that Wall Street still doesn’t fully trust. Two very…
-
Stop Trading Jim Cramer’s Personality and Start Trading the Setup
Jim Cramer says buy. The internet says fade him. So what’s the actual trade? When Cramer mentions a name like Marvell or Bausch Health, the knee-jerk reaction is tribal: either salute and hit “market buy,” or sprint to Reddit and short it out of spite. Both are lazy. The smarter move? Break down the setup,…
-
Marvell Is a Conviction Bet. Bausch Is a Redemption Story.
Jim Cramer says buy Marvell and Bausch. The real question isn’t whether he’s enthusiastic — it’s whether the stories behind MRVL and BHC are strong enough to justify chasing them right now. Here’s the blunt truth: one of these is riding a real secular wave. The other is trying to prove it’s no longer a…
-
Stop Treating Cramer’s Picks Like a Strategy
You must be logged in to post a comment.